---
title: "Tellgen Corporation (300642.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300642.SZ.md"
symbol: "300642.SZ"
name: "Tellgen Corporation"
industry: "Health Care Supplies"
datetime: "2026-05-21T02:35:19.602Z"
locales:
  - [en](https://longbridge.com/en/quote/300642.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300642.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300642.SZ.md)
---

# Tellgen Corporation (300642.SZ)

## Company Overview

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in 2003 and is based in Shanghai, China.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | CN Market |
| Website | [www.tellgen.com](https://www.tellgen.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:11.000Z

**Overall: D (0.64)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 39 / 40 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -11.24% |  |
| Net Profit YoY | -106.19% |  |
| P/B Ratio | 1.82 |  |
| Dividend Ratio | 0.94% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 2585790564.63 |  |
| Revenue | 372205654.76 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -0.17% | D |
| Profit Margin | -0.66% | D |
| Gross Margin | 64.87% | A |
| Revenue YoY | -11.24% | E |
| Net Profit YoY | -106.19% | E |
| Total Assets YoY | 19.13% | A |
| Net Assets YoY | -2.74% | D |
| Cash Flow Margin | -5526.50% | E |
| OCF YoY | -11.24% | E |
| Turnover | 0.20 | D |
| Gearing Ratio | 26.79% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Tellgen Corporation",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-11.24%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-106.19%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.82",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.94%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "2585790564.63",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "372205654.76",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-0.17%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-0.66%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "64.87%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "-11.24%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-106.19%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "19.13%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "-2.74%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-5526.50%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-11.24%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.20",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "26.79%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1033.96 | 40/40 | 195.46 | 170.95 | 69.81 |
| PB | 1.78 | 14/40 | 2.49 | 2.04 | 1.81 |
| PS (TTM) | 6.80 | 24/40 | 9.63 | 8.02 | 6.68 |
| Dividend Yield | 0.96% | - | 0.91% | 0.81% | 0.66% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Snibe (300832.SZ) | A | D | C | A | C | B |
| 02 | Winner Medical (300888.SZ) | B | B | B | B | B | B |
| 03 | Fuerjia (301371.SZ) | B | C | D | A | B | B |
| 04 | MTM (688029.SH) | B | B | B | A | B | B |
| 05 | Endovastec (688016.SH) | A | B | D | A | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2024-12-29T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 15.57 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300642.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300642.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300642.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300642.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**